Contract research news in brief
September 22, 2009Research and Development CRO
Pharmafocus' periodic round-up of developments in the contract research sector includes an acquisition and alliance for BioClinica, accreditations for ICON …
Pfizer and Icagen extend pain drug deal
September 22, 2009Research and Development Icagen, Pfizer
Pfizer has extended its existing deal with biotech Icagen, aimed at developing new treatments for pain and related disorders. Over …
AZ strikes drug development deal with Nektar Therapeutics
September 22, 2009Research and Development AZ, Nektar
AstraZeneca has licenced two anti-constipation drug development programmes from Nektar Therapeutics in a deal that could be worth more than …
Safety First
September 22, 2009Research and Development, Sales and Marketing EU, US, reg, safety
A series of high-profile drug withdrawals in recent years has brought safety concerns to the fore, prompting more rigorous monitoring …
Doctors’ leaders hit out at hospital funding proposals
September 21, 2009NHS, hc
The British Medical Association has hit out at health secretary Andy Burnham's ideas to link hospital funding to measures of …
Merck sells Merial share, but retains animal health option
September 21, 2009Sales and Marketing Merck, Merial, Sanofi, animal health
Merck & Co has got rid of its interest in animal health products company Merial prior to the merger with …
WHO welcomes pandemic vaccine donations to developing world
September 21, 2009Sales and Marketing h1n1, hc, vaccines
The World Health Organisation has applauded donations of H1N1 vaccine made by the US, Australia, Brazil, France, Italy, New Zealand, …
CambReg and SIRO forge strategic alliance
September 21, 2009Sales and Marketing generics
UK contract research organisation Cambridge Regulatory Services has teamed up with one of its Indian counterparts – SIRO Clinpharm – …
Publication bias still evident in US trials database
September 18, 2009Medical Communications, Sales and Marketing ethics
A study showing that two-thirds of clinical trials included in the US national register had no record of their primary …
Renovo cuts jobs after takeover talks fail
September 18, 2009Research and Development Renovo
UK biotech Renovo is planning to reduce its headcount by over a third after a takeover approach from an unnamed …
Daniel Vasella, chief executive and chairman Novartis
September 17, 2009Sales and Marketing Novartis, Vasella
FDA warns Bayer over German API facility
September 17, 2009Manufacturing and Production Bayer, FDA, reg
The US regulator has sent a warning letter to Bayer indicating it found "significant deviations from US current good manufacturing …
GPs gain QOF concessions in return for swine flu work
September 17, 2009NHS, qof
GPs are to administer swine flu jabs in the government’s forthcoming vaccination scheme in return for some administrative concessions.These include …
ABPI defends OLS Blueprint against member scepticism
September 17, 2009ABPI
Over half of ABPI members believe the government's latest efforts to help the life sciences sector will not make a …
Merck’s osteoporosis candidate shows some promise in trials
September 16, 2009Research and Development, Sales and Marketing Cancer, Merck
Merck & Co's investigational cathepsin K inhibitor odanacatib has shown some promise in a trial to treat osteoporosis in postmenopausal …
Conservatives leading on ‘industrial policy’ say CBI
September 16, 2009Research and Development ABPI, hc, reform
A change of government would benefit UK pharma, according to the Confederation of British Industry, which says the industry might …
Puerto Rican ops hold back Patheon
September 16, 2009Manufacturing and Production Patheon
Canadian contract manufacturer Patheon has reported ‘disappointing’ third-quarter results, with a resurgence of problems at its Puerto Rican operations contributing …
Pharma calls for action to boost medicines research
September 16, 2009Sales and Marketing ABPI
A better environment for the UK life sciences sector is vital for the country's economic recovery, according to the Association …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
